Metabomed
PrivateLast Round
Series B
Dec 19, 2019
Total Funding Raised
$35.5M
Company Overview
Metabomed operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Series B round in December 2019.
Metabomed is a biotechnology company that develops small molecule drugs directed against novel targets in the field of cancer metabolism.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metabomed Comparables
Compare Metabomed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReEngage Therapeutics | 80% | |
| Lime Therapeutics | 73% | |
| KSQ Therapeutics | 71% |
For institutional investors. Book with your work email.
Metabomed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 19, 2019 | ||||
| Series A | Apr 4, 2016 | ||||
| Seed | Nov 28, 2013 |
For institutional investors. Book with your work email.
Metabomed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| M Ventures | Series A, Series B, Seed |
| Pontifax Venture Capital | Series A, Seed |
| Boehringer Ingelheim Venture Fund | Series A, Seed, Series B |
| Pfizer | Series A |
| Arkin Bio Ventures | Series B |
| Pfizer Ventures | Series B |
| Technion Research & Development Foundation | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 19, 2019
$13M round with participation from Pfizer Ventures and M Ventures.
- Apr 4, 2016
$18M round with participation from Pfizer and Boehringer Ingelheim.
For institutional investors. Book with your work email.
Metabomed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Metabomed's valuation, stock price, and market status.
Is Metabomed a public or private company?
Metabomed is a private company.
What is the current stock price of Metabomed?
Metabomed is a private company, so its shares have no public market price. Caplight tracks Metabomed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Metabomed worth (valuation)?
Valuation information for Metabomed is not publicly available.
Can I buy Metabomed stock?
Metabomed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Metabomed's last funding round?
Metabomed's most recent funding round was Series B on December 19, 2019.
Who are the main investors in Metabomed?
Key investors in Metabomed include M Ventures.
Will Metabomed IPO soon?
No public IPO plans have been announced for Metabomed.
How can I track Metabomed secondary market activity?
Caplight tracks bids, offers, and trades in Metabomed's shares on secondary markets.